Could a first-trimester blood phosphatidylethanol concentration ⩾4 nM be useful to identify women with moderate-to-heavy prenatal alcohol exposure who are at high risk of adverse pregnancy outcomes?
Introduction
Neither ingestion of light amounts of alcohol during pregnancy nor exposure limited to the first trimester of pregnancy has been found to be associated with an increased risk of adverse pregnancy outcomes such as spontaneous abortions or babies born small for gestational age [1], [2]. However, as the level and length of prenatal alcohol exposure increase, the risk of adverse pregnancy outcomes also increases. For example, ingestion of 2–4 drinks/week during pregnancy is associated with an increased risk of low birth weight and neonatal asphyxia [3]. Spontaneous abortions occurred in approximately 9% of pregnant women ingesting ⩾5 drinks/week [4].
Surprisingly, this dose–response effect between prenatal alcohol exposure and adverse pregnancy outcomes is far from being established in a definitive way. For example, a Danish cohort study found that even low amounts of alcohol consumption during early pregnancy increased the risk of spontaneous abortion substantially [5]. On the other side of the spectrum, two large European cohort studies and a systematic review of epidemiological studies failed to confirm any increased risk of adverse pregnancy outcomes among women who reported a daily ingestion of 1–1.5 drinks of alcohol [6], [7], even among women who were disadvantaged in terms of low education, high levels of distress, or smoking during pregnancy [6].
Although these contradictory results could be partially explained by a variety of methodological differences across studies, problems associated with the reliability of alcohol ingestion self-reported by participants could be a major factor explaining such differences. This problem could easily be overcome if epidemiological studies could incorporate a robust and inexpensive indicator of prenatal alcohol ingestion. Unfortunately, despite efforts to identify such biomarker conducted by several groups of investigators, independently, there is not yet one that could be considered as the gold standard.
Section snippets
The hypotheses
The short half-life of ethanol itself, as well as of that of its major oxidative metabolite acetaldehyde, limit their use as biomarkers of prenatal alcohol exposure in the clinical setting. Indirect biomarkers of prenatal alcohol exposure such as gamma glutamyltranspeptidase and mean corpuscular volume have shown poor sensitivity in pregnant women [8], [9]. However, non-oxidative metabolites of ethanol, such as phosphatidylethanol (PEth), have generated interest for their theoretically high
Participants
The study, conducted in compliance of the World Medical Association Declaration of Helsinki regarding ethical conduct of research involving human subjects, was based on a prospective follow-up of 284 participants who previously participated in the characterization of blood PEth concentration as a biomarker of prenatal alcohol exposure [11]. Briefly, after receiving approval by the institutional review board at the Cheil General Hospital and Women’s Healthcare Center, Seoul, Republic of Korea,
Consequences of the hypothesis and discussion
Extensive efforts have been made to identify biomarkers of prenatal alcohol exposure which, in turn, can help to identify those babies at risk of ethanol-related postnatal developmental alterations. In this context, the present study provides preliminary evidence to consider PEth as a promising biomarker to study the link between prenatal alcohol exposure and high risk of adverse pregnancy outcomes. A further, more detailed confirmation of these findings would have several important
Conflict of interest
The authors stated that there are no conflicts of interest regarding the publication of this article. No support was received, in any form, from the manufacturers or distributors of the reagents or equipment cited in the document.
Statement of author contributions
J.Y. Yang, J.Y. Han, and Y.J. Oh participated in the conception and design of the study. H.S. Kwak implemented the analytical methods and conducted all the laboratory analysis. Y. Han, J.S. Choi, and H.-K. Ahn recruited the participants and collected the blood samples. J.Y. Yang, J.Y. Han, Y.J. Oh, E.Y. Velázquez-Armenta, and A.A. Nava-Ocampo conducted the statistical analysis and drafted the interpretation of the results. All authors participated in the preparation of the manuscript and the
References (15)
- et al.
Foetal and neonatal outcomes in women reporting ingestion of low or very low alcohol intake during pregnancy
J Matern Fetal Neonatal Med
(2012) - et al.
Association between maternal alcohol consumption in early pregnancy and pregnancy outcomes
Obstet Gynecol
(2013) - et al.
Association of moderate alcohol use and binge drinking during pregnancy with neonatal health
Alcohol Clin Exp Res
(2011) - et al.
Moderate alcohol intake in pregnancy and the risk of spontaneous abortion
Alcohol Alcohol
(2002) - et al.
Moderate alcohol intake during pregnancy and risk of fetal death
Int J Epidemiol
(2012) - et al.
Preterm birth and small for gestational age in relation to alcohol consumption during pregnancy: stronger associations among vulnerable women? Results from two large Western-European studies
BMC Pregnancy Childbirth
(2013) - et al.
Dose–response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA) – a systematic review and meta-analyses
BJOG
(2011)
Cited by (8)
Screening for prenatal alcohol exposure and corresponding short-term neonatal outcomes
2019, Reproductive ToxicologyCitation Excerpt :Due to these limitations associated with EtG and other alcohol markers, PEth DBS testing has generated significant interest as a potential method for PAE detection due to ease of collection, transport, storage and processing of samples, lower analysis cost, and high sensitivity for ethanol exposure [29,30]. Women with blood PEth concentrations greater than 4 nM and who self-reported alcohol consumption in the first trimester had increased risk for spontaneous abortions [31]. Additionally, previous studies have analyzed PEth levels in DBS obtained as part of routine, state-mandated, newborn screening as a means to measure PAE.
Assessing prevalence of alcohol consumption in early pregnancy: Self-report compared to blood biomarker analysis
2018, European Journal of Medical GeneticsCitation Excerpt :Blood biomarker analysis offers the possibility of a more objective assessment. For the most commonly recognised blood biomarkers (e.g. CDT, GGT, phosphatidylethanol, aspartate aminotransferase and alanine aminotransferase), the threshold for a positive test is only reached with sustained drinking over a period of 2–3 weeks (Comasco et al., 2012; Kwak et al., 2014; Stoler et al., 1998; Yang et al., 2015). As such, it only offers a cross-sectional picture and may omit moderate drinkers or not reflect behaviour over the long-term.
How strong is the evidence for using blood biomarkers alone to screen for alcohol consumption during pregnancy? A systematic review
2017, European Journal of Obstetrics and Gynecology and Reproductive BiologyCitation Excerpt :A meta-analysis was not possible due to the small number of included studies. Eight studies met our inclusion criteria, although two studies were of the same population [26,27]. Settings and designs are summarised in Table 2.
Objective assessment of alcohol consumption in early pregnancy using phosphatidylethanol: a cross‐sectional study
2021, BMC Pregnancy and ChildbirthPhosphatidylethanol as Blood Biomarker of Alcohol Consumption in Early Pregnancy: An Observational Study in 4,067 Pregnant Women
2021, Alcoholism: Clinical and Experimental Research